Safa'a Al-Rais

Chief Operating Officer at Resilience Biotechnologies, Inc.

Health Technology

Profile

Safa'a Al-Rais is currently the Chief Operating Officer at Resilience Biotechnologies, Inc. Prior to this, he worked at Therapure Biopharma, Inc. from 2009 to 2020 as the Vice President-Operations.

Safa'a Al-Rais active positions

Companies	Position	Start
Resilience Biotechnologies, Inc. Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi.	Chief Operating Officer	-

All active positions of Safa'a Al-Rais

Former positions of Safa'a Al-Rais

Companies	Position	End
Therapure Biopharma, Inc. Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.	Chief Operating Officer	01/10/2020

See the detail of Safa'a Al-Rais's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Safa'a Al-Rais's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Therapure Biopharma, Inc. Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.	Health Technology
Resilience Biotechnologies, Inc. Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi.	Health Technology